E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
31 / 08 / 2016

 


Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension

Mustafa Raja, Ajay Kumar Shukla, Rekha Mehani, Astha Agnihotri.


Abstract
Background: Hypertension has been termed the silent killer; an asymptomatic chronic disorder that, if undetected and untreated, silently damages the blood vessels, heart, brain, and kidneys. In India, hypertension is emerging as a major health problem and is more prevalent in urban than in rural subjects. Hypertension is directly responsible for 57% of all stroke deaths and 24% of all coronary heart disease deaths in India.

Aims and Objectives: To compare the efficacy of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension.

Materials and Methods: This study was a hospital-based prospective, randomized, comparative, observational study conducted over a period of 1-year. For the purpose of this study, equal numbers of mild to moderate hypertensive patients were randomly allocated equally between two groups: one group on telmisartan and the other group on ramipril. Patients were assessed for the blood pressure (BP) reduction during follow-up period of 6-month.

Results: In both telmisartan and ramipril groups, there was a significant reduction of systolic BP (SBP), diastolic BP (DBP), and mean BP (MBP) from beginning to the end of study (P < 0.001). There was a significant difference in reduction of SBP and MBP during 4-12 weeks (P < 0.001) between telmisartan and ramipril group but no significant difference in the reduction of SBP and MBP in both drug groups was seen at the end of the study.

Conclusion: Both telmisartan and ramipril groups were similar and comparable with regards to their SBP and DBP. In both telmisartan and ramipril groups, there was a significant reduction of SBP, DBP, and MBP from beginning to the end of study (P < 0.001).

Key words: Hypertension; Angiotensin-converting Enzyme Inhibitors; Angiotensin Receptors Blockers; Renin-angiotensin System


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mustafa Raja
Articles by Ajay Kumar Shukla
Articles by Rekha Mehani
Articles by Astha Agnihotri
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Mustafa Raja, Ajay Kumar Shukla, Rekha Mehani, Astha Agnihotri. Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension. Natl J Physiol Pharm Pharmacol. 2016; 6(5): 388-393. doi:10.5455/njppp.2016.6.0409001052016


Web Style

Mustafa Raja, Ajay Kumar Shukla, Rekha Mehani, Astha Agnihotri. Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension. https://www.njppp.com/?mno=221737 [Access: March 15, 2024]. doi:10.5455/njppp.2016.6.0409001052016


AMA (American Medical Association) Style

Mustafa Raja, Ajay Kumar Shukla, Rekha Mehani, Astha Agnihotri. Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension. Natl J Physiol Pharm Pharmacol. 2016; 6(5): 388-393. doi:10.5455/njppp.2016.6.0409001052016



Vancouver/ICMJE Style

Mustafa Raja, Ajay Kumar Shukla, Rekha Mehani, Astha Agnihotri. Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension. Natl J Physiol Pharm Pharmacol. (2016), [cited March 15, 2024]; 6(5): 388-393. doi:10.5455/njppp.2016.6.0409001052016



Harvard Style

Mustafa Raja, Ajay Kumar Shukla, Rekha Mehani, Astha Agnihotri (2016) Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension. Natl J Physiol Pharm Pharmacol, 6 (5), 388-393. doi:10.5455/njppp.2016.6.0409001052016



Turabian Style

Mustafa Raja, Ajay Kumar Shukla, Rekha Mehani, Astha Agnihotri. 2016. Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension. National Journal of Physiology, Pharmacy and Pharmacology, 6 (5), 388-393. doi:10.5455/njppp.2016.6.0409001052016



Chicago Style

Mustafa Raja, Ajay Kumar Shukla, Rekha Mehani, Astha Agnihotri. "Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension." National Journal of Physiology, Pharmacy and Pharmacology 6 (2016), 388-393. doi:10.5455/njppp.2016.6.0409001052016



MLA (The Modern Language Association) Style

Mustafa Raja, Ajay Kumar Shukla, Rekha Mehani, Astha Agnihotri. "Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension." National Journal of Physiology, Pharmacy and Pharmacology 6.5 (2016), 388-393. Print. doi:10.5455/njppp.2016.6.0409001052016



APA (American Psychological Association) Style

Mustafa Raja, Ajay Kumar Shukla, Rekha Mehani, Astha Agnihotri (2016) Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension. National Journal of Physiology, Pharmacy and Pharmacology, 6 (5), 388-393. doi:10.5455/njppp.2016.6.0409001052016